US EditionWeight-Loss Jabs Could Minimise the Symptoms of Asthma
UNITED KINGDOM, JUL 24 – An analysis of over 60,000 UK patients found weight-loss jabs improved asthma control in obese individuals despite only modest average weight loss of 0.9kg, researchers said.
- Researchers found that weight-loss jabs such as Mounjaro could help minimise asthma symptoms in obese people after analysing 10,111 on GLP1-RAs versus 50,555 not on them, showing potential benefits beyond weight loss.
- People with obesity and asthma are often resistant to steroid treatments, and Professor David Price said: `GLP-1s work on inflammatory responses in the airways in a different way.`
- Follow-Up results showed that weight-loss jabs led to greater weight loss and improved asthma control, with Professor David Price attributing benefits to modest 0.9kg weight loss despite the follow-up period.
- According to Prof Alan Kaplan and colleagues, weight-loss jabs warrant consideration in managing asthma among obese patients, as research suggests that GLP1-RAs have benefits on asthma control in people with obesity, and this information should contribute to the discussions around the decision to use these drugs.
- According to NICE, eligibility for weight-loss jabs could expand to over three million Brits, and researchers say more study is needed to understand how these drugs improve asthma control.
38 Articles
38 Articles
Weight loss jabs could improve asthma symptoms in people with obesity, study finds
New research indicates that medications commonly prescribed for weight reduction might offer significant benefits for asthma sufferers who struggle with obesity, extending beyond simple weight management. The study reveals these drugs could provide relief through mechanisms distinct from conventional steroid treatments.Scientists have discovered that glucagon-like peptide-1 receptor agonists, including medications such as Ozempic, may influence …
GLP1 weight loss injections may reduce asthma symptoms
GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people according to a new study from the University of Aberdeen and the Observational and Pragmatic Research Institute (OPRI), Singapore.
Bristol Post
Wales OnlineWeight-loss jabs could minimise the symptoms of asthma
They were initially developed as a treatment for people with type 2 diabetes
Chester Standard
Weight-loss jabs such as Mounjaro could help obese people control asthma
Weight-loss jabs such as Mounjaro could also help minimise asthma symptoms in obese people, says a new study, as the NHS rolls out treatment for…
Coverage Details
Bias Distribution
- 77% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
